Neurocrine Biosciences Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2016 | $50.2M | $365.1M | $83.3M |
| FY2017 | $445.5M | $817.6M | $254.7M |
| FY2018 | $512.4M | $993.2M | $141.7M |
| FY2019 | $669.1M | $1.31B | $112.3M |
| FY2020 | $608.5M | $1.73B | $187.1M |
| FY2021 | $698.5M | $2.07B | $340.8M |
| FY2022 | $660.9M | $2.37B | $262.9M |
| FY2023 | $1.02B | $3.25B | $251.1M |
| FY2024 | $1.13B | $3.72B | $233.0M |
| FY2025 | $1.38B | $4.63B | $713.0M |